G2 Investment Partners Management LLC Axogen, Inc. Transaction History

G2 Investment Partners Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$17.8 - $23.5 $3.87 Million - $5.11 Million	-217,600 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$17.18 - $22.6 $4.57 Million - $6.01 Million	-265,761 Reduced 54.98%	217,600 $4.41 Million
Q4 2020 Feb 16, 2021	SELL	$11.5 - $17.96 $1.28 Million - $2 Million	-111,311 Reduced 18.72%	483,361 $8.65 Million
Q3 2020 Nov 16, 2020	BUY	$10.62 - $13.12 $1.75 Million - $2.17 Million	165,214 Added 38.47%	594,672 $6.92 Million
Q2 2020 Aug 14, 2020	BUY	$7.35 - $10.81 $3.16 Million - $4.64 Million	429,458 New	429,458 $3.97 Million
Q1 2019 May 15, 2019	SELL	$14.62 - $22.13 $2.26 Million - $3.42 Million	-154,370 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $2.64 Million - $5.9 Million	154,370 New	154,370 $3.15 Million

176

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of G2 Investment Partners Management LLC, based on Form 13F filings with the SEC.

Stay updated on G2 Investment Partners Management LLC with notifications on news.